Alldrick A J, Cottrell R C, Rowland I R, Gangolli S D
Carcinogenesis. 1985 Jan;6(1):105-8. doi: 10.1093/carcin/6.1.105.
The cytotoxic and mutagenic effects of increasing concentrations of N-nitrosopyrrolidine (NPYR) were studied using various DNA repair mutants of Escherichia coli together with rat-liver S9 activation system. Irrespective of which strain was used, the cytotoxic effects of NPYR were similar to those observed in the parent strain. Mutagenicity studies revealed that the uvrA- derivative was more mutable than its repair proficient parent. These observations suggest that NPYR reacts with DNA to generate bulky lesions, which although potentially mutagenic, do not contribute significantly to cell-killing. Subsequent experiments with the metabolic inhibitor SKF 525A revealed that this compound only partially inhibited the mutagenic activity of NPYR, suggesting that although hepatic mixed function oxidase enzymes may participate in NPYR activation other pathways of metabolism are also involved.
使用大肠杆菌的各种DNA修复突变体以及大鼠肝脏S9激活系统,研究了浓度不断增加的N-亚硝基吡咯烷(NPYR)的细胞毒性和致突变性。无论使用哪种菌株,NPYR的细胞毒性作用都与在亲本菌株中观察到的相似。致突变性研究表明,uvrA-衍生物比其具有修复能力的亲本更易发生突变。这些观察结果表明,NPYR与DNA反应产生大分子损伤,这些损伤虽然具有潜在的致突变性,但对细胞杀伤作用不大。随后用代谢抑制剂SKF 525A进行的实验表明,该化合物仅部分抑制了NPYR的致突变活性,这表明尽管肝脏混合功能氧化酶可能参与NPYR的激活,但其他代谢途径也有涉及。